<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35418691</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1476-5594</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>41</Volume>
            <Issue>20</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Oncogene</Title>
          <ISOAbbreviation>Oncogene</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nuclear receptor coactivator SRC-1 promotes colorectal cancer progression through enhancing GLI2-mediated Hedgehog signaling.</ArticleTitle>
        <Pagination>
          <StartPage>2846</StartPage>
          <EndPage>2859</EndPage>
          <MedlinePgn>2846-2859</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41388-022-02308-8</ELocationID>
        <Abstract>
          <AbstractText>Overexpression of nuclear coactivator steroid receptor coactivator 1 (SRC-1) and aberrant activation of the Hedgehog (Hh) signaling pathway are associated with various tumorigenesis; however, the significance of SRC-1 in colorectal cancer (CRC) and its contribution to the activation of Hh signaling are unclear. Here, we identified a conserved Hh signaling signature positively correlated with SRC-1 expression in CRC based on TCGA database; SRC-1 deficiency significantly inhibited the proliferation, survival, migration, invasion, and tumorigenesis of both human and mouse CRC cells, and SRC-1 knockout significantly suppressed azoxymethane/dextran sodium sulfate (AOM/DSS)-induced CRC in mice. Mechanistically, SRC-1 promoted the expression of GLI family zinc finger 2 (GLI2), a major downstream transcription factor of Hh pathway, and cooperated with GLI2 to enhance multiple Hh-regulated oncogene expression, including Cyclin D1, Bcl-2, and Slug. Pharmacological blockages of SRC-1 and Hh signaling retarded CRC progression in human CRC cell xenograft mouse model. Together, our studies uncover an SRC-1/GLI2-regulated Hh signaling looping axis that promotes CRC tumorigenesis, offering an attractive strategy for CRC treatment.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Guo</LastName>
            <ForeName>Peng</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, 361102, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Chen</LastName>
            <ForeName>Qiang</ForeName>
            <Initials>Q</Initials>
            <Identifier Source="ORCID">0000-0003-2624-8904</Identifier>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, 361102, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Peng</LastName>
            <ForeName>Kesong</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">0000-0001-9035-3421</Identifier>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, 361102, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, 200433, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xie</LastName>
            <ForeName>Jianyuan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, 361102, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Junjia</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, 361102, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Institute for Data Science in Health and Medicine Engineering, Research Center of Molecular Diagnostics of the Ministry of Education, School of Life Sciences, Xiamen University, Xiamen, Fujian, 361102, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ren</LastName>
            <ForeName>Wenjing</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, 361102, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tong</LastName>
            <ForeName>Zhangwei</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, 361102, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Ming</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-9700-1282</Identifier>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, 361102, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Jianming</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-8208-9162</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Yongyou</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">0000-0003-2413-9106</Identifier>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, 361102, China. yongyouzhang@xmu.edu.cn.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Institute for Data Science in Health and Medicine Engineering, Research Center of Molecular Diagnostics of the Ministry of Education, School of Life Sciences, Xiamen University, Xiamen, Fujian, 361102, China. yongyouzhang@xmu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Chundong</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0002-4141-8345</Identifier>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, 361102, China. cdyu@xmu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mo</LastName>
            <ForeName>Pingli</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0002-4913-2042</Identifier>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, 361102, China. mop@xmu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Oncogene</MedlineTA>
        <NlmUniqueID>8711562</NlmUniqueID>
        <ISSNLinking>0950-9232</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C082593">GLI2 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053823">Hedgehog Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000075746">Zinc Finger Protein Gli2</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.3.1.48</RegistryNumber>
          <NameOfSubstance UI="C538859">NCOA1 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.3.1.48</RegistryNumber>
          <NameOfSubstance UI="D056920">Nuclear Receptor Coactivator 1</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063646" MajorTopicYN="N">Carcinogenesis</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015179" MajorTopicYN="Y">Colorectal Neoplasms</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053823" MajorTopicYN="Y">Hedgehog Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056920" MajorTopicYN="Y">Nuclear Receptor Coactivator 1</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000075746" MajorTopicYN="N">Zinc Finger Protein Gli2</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>14</Day>
          <Hour>5</Hour>
          <Minute>19</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35418691</ArticleId>
        <ArticleId IdType="doi">10.1038/s41388-022-02308-8</ArticleId>
        <ArticleId IdType="pii">10.1038/s41388-022-02308-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>O’Malley BW, Kumar R. Nuclear receptor coregulators in cancer biology. Cancer Res. 2009;69:8217–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19843848</ArticleId>
            <ArticleId IdType="pmc">2783444</ArticleId>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-09-2223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lonard DM, O’Malley BW. Nuclear receptor coregulators: modulators of pathology and therapeutic targets. Nat Rev Endocrinol. 2012;8:598–604.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22733267</ArticleId>
            <ArticleId IdType="pmc">3564250</ArticleId>
            <ArticleId IdType="doi">10.1038/nrendo.2012.100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mark M, Yoshida-Komiya H, Gehin M, Liao L, Tsai MJ, O’Malley BW, et al. Partially redundant functions of SRC-1 and TIF2 in postnatal survival and male reproduction. Proc Natl Acad Sci USA. 2004;101:4453–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15070739</ArticleId>
            <ArticleId IdType="pmc">384768</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.0400234101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu J, Qiu Y, DeMayo FJ, Tsai SY, Tsai MJ, O’Malley BW. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 1998;279:1922–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9506940</ArticleId>
            <ArticleId IdType="doi">10.1126/science.279.5358.1922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Picard F, Géhin M, Annicotte J, Rocchi S, Champy MF, O’Malley BW, et al. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 2002;111:931–41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12507421</ArticleId>
            <ArticleId IdType="doi">10.1016/S0092-8674(02)01169-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Louet JF, Chopra AR, Sagen JV, An J, York B, Tannour-Louet M, et al. The coactivator SRC-1 is an essential coordinator of hepatic glucose production. Cell Metab. 2010;12:606–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21109193</ArticleId>
            <ArticleId IdType="pmc">3024581</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cmet.2010.11.009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duteil D, Chambon C, Ali F, Malivindi R, Zoll J, Kato S, et al. The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles. Cell Metab. 2010;12:496–508.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21035760</ArticleId>
            <ArticleId IdType="pmc">3032428</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cmet.2010.09.016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walsh CA, Bolger JC, Byrne C, Cocchiglia S, Hao Y, Fagan A, et al. Global gene repression by the steroid receptor coactivator SRC-1 promotes oncogenesis. Cancer Res. 2014;74:2533–44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24648347</ArticleId>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-13-2133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qin L, Wu YL, Toneff MJ, Li D, Liao L, Gao X, et al. NCOA1 directly targets M-CSF1 expression to promote breast cancer metastasis. Cancer Res. 2014;74:3477–88.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24769444</ArticleId>
            <ArticleId IdType="pmc">4083628</ArticleId>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-13-2639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Lonard DM, Yu Y, Chow DC, Palzkill TG, O’Malley BW. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1. Mol Endocrinol. 2011;25:2041–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22053001</ArticleId>
            <ArticleId IdType="pmc">3231837</ArticleId>
            <ArticleId IdType="doi">10.1210/me.2011-1222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qin L, Chen X, Wu Y, Feng Z, He T, Wang L, et al. Steroid receptor coactivator-1 upregulates integrin α<sub>s</sub> expression to promote breast cancer cell adhesion and migration. Cancer Res. 2011;71:1742–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21343398</ArticleId>
            <ArticleId IdType="pmc">3076137</ArticleId>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-10-3453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu J, Wu RC, O’Malley BW. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer. 2009;9:615–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19701241</ArticleId>
            <ArticleId IdType="pmc">2908510</ArticleId>
            <ArticleId IdType="doi">10.1038/nrc2695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giudici M, Goni S, Fan R, Treuter E. Nuclear receptor coregulators in metabolism and disease. Handb Exp Pharm. 2016;233:95–135.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/164_2015_5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kato S, Yokoyama A, Fujiki R. Nuclear receptor coregulators merge transcriptional coregulation with epigenetic regulation. Trends Biochem Sci. 2011;36:272–81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21315607</ArticleId>
            <ArticleId IdType="doi">10.1016/j.tibs.2011.01.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsia EY, Goodson ML, Zou JX, Privalsky ML, Chen HW. Nuclear receptor coregulators as a new paradigm for therapeutic targeting. Adv Drug Deliv Rev. 2010;62:1227–37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20933027</ArticleId>
            <ArticleId IdType="pmc">5004779</ArticleId>
            <ArticleId IdType="doi">10.1016/j.addr.2010.09.016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Na SY, Lee SK, Han SJ, Choi HS, Im SY, Lee JW. Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor kappaB-mediated transactivations. J Biol Chem. 1998;273:10831–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9556555</ArticleId>
            <ArticleId IdType="doi">10.1074/jbc.273.18.10831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee SK, Kim HJ, Kim JW, Lee JW. Steroid receptor coactivator-1 and its family members differentially regulate transactivation by the tumor suppressor protein p53. Mol Endocrinol. 1999;13:1924–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10551785</ArticleId>
            <ArticleId IdType="doi">10.1210/mend.13.11.0365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Myers E, Hill AD, Kelly G, McDermott EW, O’Higgins NJ, Buggy Y, et al. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer. Clin Cancer Res. 2005;11:2111–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15788656</ArticleId>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-04-1192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Russo L, Giller K, Pfitzner E, Griesinger C, Becker S. Insight into the molecular recognition mechanism of the coactivator NCoA1 by STAT6. Sci Rep. 2017;7:16845.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29203888</ArticleId>
            <ArticleId IdType="pmc">5714956</ArticleId>
            <ArticleId IdType="doi">10.1038/s41598-017-17088-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang S, Yuan Y, Liao L, Kuang SQ, Tien JC, O’Malley BW, et al. Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation. Proc Natl Acad Sci USA. 2009;106:151–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19109434</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.0808703105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qin L, Liu Z, Chen H, Xu J. The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis. Cancer Res. 2009;69:3819–27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19383905</ArticleId>
            <ArticleId IdType="pmc">2911143</ArticleId>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-08-4389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meerson A, Yehuda H. Leptin and insulin up-regulate miR-4443 to suppress NCOA1 and TRAF4, and decrease the invasiveness of human colon cancer cells. BMC Cancer. 2016;16:882.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27842582</ArticleId>
            <ArticleId IdType="pmc">5109693</ArticleId>
            <ArticleId IdType="doi">10.1186/s12885-016-2938-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tong Z, Li M, Wang W, Mo P, Yu L, Liu K, et al. Steroid receptor coactivator 1 promotes human hepatocellular carcinoma progression by enhancing Wnt/β-Catenin signaling. J Biol Chem. 2015;290:18596–608.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26082485</ArticleId>
            <ArticleId IdType="pmc">4513118</ArticleId>
            <ArticleId IdType="doi">10.1074/jbc.M115.640490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walsh CA, Qin L, Tien JC, Young LS, Xu J. The function of steroid receptor coactivator-1 in normal tissues and cancer. Int J Biol Sci. 2012;8:470–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22419892</ArticleId>
            <ArticleId IdType="pmc">3303173</ArticleId>
            <ArticleId IdType="doi">10.7150/ijbs.4125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeng X, Goetz JA, Suber LM, Scott WJ Jr., Schreiner CM, Robbins DJ. A freely diffusible form of Sonic hedgehog mediates long-range signalling. Nature. 2001;411:716–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11395778</ArticleId>
            <ArticleId IdType="doi">10.1038/35079648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Briscoe J, Thérond PP. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol. 2013;14:416–29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23719536</ArticleId>
            <ArticleId IdType="doi">10.1038/nrm3598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao C, Cai S, Shin K, Lim A, Kalisky T, Lu WJ, et al. Stromal Gli2 activity coordinates a niche signaling program for mammary epithelial stem cells. Science. 2017;356.</Citation>
        </Reference>
        <Reference>
          <Citation>Du K, Hyun J, Premont RT, Choi SS, Michelotti GA, Swiderska-Syn M, et al. Hedgehog-YAP signaling pathway regulates glutaminolysis to control activation of hepatic stellate cells. Gastroenterology. 2018;154:1465–79.e1413.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29305935</ArticleId>
            <ArticleId IdType="doi">10.1053/j.gastro.2017.12.022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sari IN, Phi LTH, Jun N, Wijaya YT, Lee S, Kwon HY. Hedgehog signaling in cancer: a prospective therapeutic target for eradicating cancer stem cells. Cells. 2018;7:208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">6262325</ArticleId>
            <ArticleId IdType="doi">10.3390/cells7110208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sang Y, Li Y, Song L, Alvarez AA, Zhang W, Lv D, et al. TRIM59 promotes gliomagenesis by inhibiting TC45 dephosphorylation of STAT3. Cancer Res. 2018;78:1792–804.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29386185</ArticleId>
            <ArticleId IdType="pmc">5882560</ArticleId>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-17-2774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raleigh DR, Choksi PK, Krup AL, Mayer W, Santos N, Reiter JF. Hedgehog signaling drives medulloblastoma growth via CDK6. J Clin Invest. 2018;128:120–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29202464</ArticleId>
            <ArticleId IdType="doi">10.1172/JCI92710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fattahi S, Pilehchian Langroudi M, Akhavan-Niaki H. Hedgehog signaling pathway: epigenetic regulation and role in disease and cancer development. J Cell Physiol. 2018;233:5726–35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29380372</ArticleId>
            <ArticleId IdType="doi">10.1002/jcp.26506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeng X, Ju D. Hedgehog signaling pathway and autophagy in cancer. Int J Mol Sci. 2018;19:2279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">6121518</ArticleId>
            <ArticleId IdType="doi">10.3390/ijms19082279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Papadopoulos V, Tsapakidis K, Riobo Del Galdo NA, Papandreou CN, Del Galdo F, Anthoney A, et al. The prognostic significance of the hedgehog signaling pathway in colorectal cancer. Clin Colorectal Cancer. 2016;15:116–27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27032873</ArticleId>
            <ArticleId IdType="doi">10.1016/j.clcc.2016.02.010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kangwan N, Kim YJ, Han YM, Jeong M, Park JM, Go EJ, et al. Sonic hedgehog inhibitors prevent colitis-associated cancer via orchestrated mechanisms of IL-6/gp130 inhibition, 15-PGDH induction, Bcl-2 abrogation, and tumorsphere inhibition. Oncotarget 2016;7:7667–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26716648</ArticleId>
            <ArticleId IdType="doi">10.18632/oncotarget.6765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46:D956–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29136207</ArticleId>
            <ArticleId IdType="doi">10.1093/nar/gkx1090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu J, Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol. 2003;17:1681–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12805412</ArticleId>
            <ArticleId IdType="doi">10.1210/me.2003-0116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hui CC, Angers S. Gli proteins in development and disease. Annu Rev Cell Dev Biol. 2011;27:513–37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21801010</ArticleId>
            <ArticleId IdType="doi">10.1146/annurev-cellbio-092910-154048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Lonard DM, Yu Y, Chow DC, Palzkill TG, Wang J, et al. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1. Cancer Res. 2014;74:1506–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24390736</ArticleId>
            <ArticleId IdType="pmc">3947477</ArticleId>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-13-2939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dlugosz A, Agrawal S, Kirkpatrick P. Vismodegib. Nat Rev Drug Disco. 2012;11:437–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrd3753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Q, Zhuang S, Hong Y, Yang L, Guo P, Mo P, et al. Demethylase JMJD2D induces PD-L1 expression to promote colorectal cancer immune escape by enhancing IFNGR1-STAT3-IRF1 signaling. Oncogene 2022;41:1421–33.</Citation>
        </Reference>
        <Reference>
          <Citation>Peng K, Zhuo M, Li M, Chen Q, Mo P, Yu C. Histone demethylase JMJD2D activates HIF1 signaling pathway via multiple mechanisms to promote colorectal cancer glycolysis and progression. Oncogene 2020;39:7076–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32989255</ArticleId>
            <ArticleId IdType="doi">10.1038/s41388-020-01483-w</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhuo M, Chen W, Shang S, Guo P, Peng K, Li M, et al. Inflammation-induced JMJD2D promotes colitis recovery and colon tumorigenesis by activating Hedgehog signaling. Oncogene 2020;39:3336–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32094404</ArticleId>
            <ArticleId IdType="doi">10.1038/s41388-020-1219-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng K, Kou L, Yu L, Bai C, Li M, Mo P, et al. Histone demethylase JMJD2D interacts with β-Catenin to induce transcription and activate colorectal cancer cell proliferation and tumor growth in mice. Gastroenterology 2019;156:1112–26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30472235</ArticleId>
            <ArticleId IdType="doi">10.1053/j.gastro.2018.11.036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madison BB, Braunstein K, Kuizon E, Portman K, Qiao XT, Gumucio DL. Epithelial hedgehog signals pattern the intestinal crypt-villus axis. Development 2005;132:279–89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15590741</ArticleId>
            <ArticleId IdType="doi">10.1242/dev.01576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varnat F, Duquet A, Malerba M, Zbinden M, Mas C, Gervaz P, et al. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med. 2009;1:338–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20049737</ArticleId>
            <ArticleId IdType="pmc">3378144</ArticleId>
            <ArticleId IdType="doi">10.1002/emmm.200900039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain S, Song R, Xie J. Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas. Onco Targets Ther. 2017;10:1645–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28352196</ArticleId>
            <ArticleId IdType="pmc">5360396</ArticleId>
            <ArticleId IdType="doi">10.2147/OTT.S130910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xin M, Ji X, De La Cruz LK, Thareja S, Wang B. Strategies to target the Hedgehog signaling pathway for cancer therapy. Med Res Rev. 2018;38:870–913.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29315702</ArticleId>
            <ArticleId IdType="doi">10.1002/med.21482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berlin J, Bendell JC, Hart LL, Firdaus I, Gore I, Hermann RC, et al. A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer. Clin Cancer Res. 2013;19:258–67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23082002</ArticleId>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-12-1800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Catenacci DV, Junttila MR, Karrison T, Bahary N, Horiba MN, Nattam SR, et al. Randomized Phase Ib/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer. J Clin Oncol. 2015;33:4284–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26527777</ArticleId>
            <ArticleId IdType="pmc">4678179</ArticleId>
            <ArticleId IdType="doi">10.1200/JCO.2015.62.8719</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mo P, Zhou Q, Guan L, Wang Y, Wang W, Miao M, et al. Amplified in breast cancer 1 promotes colorectal cancer progression through enhancing notch signaling. Oncogene 2015;34:3935–45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25263446</ArticleId>
            <ArticleId IdType="doi">10.1038/onc.2014.324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Datta A, Biswas K, Sommers JA, Thompson H, Awate S, Nicolae CM, et al. WRN helicase safeguards deprotected replication forks in BRCA2-mutated cancer cells. Nat Commun. 2021;12:6561.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34772932</ArticleId>
            <ArticleId IdType="pmc">8590011</ArticleId>
            <ArticleId IdType="doi">10.1038/s41467-021-26811-w</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin J, Liu H, Fukumoto T, Zundell J, Yan Q, Tang CA, et al. Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer. Nat Commun. 2021;12:5321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34493732</ArticleId>
            <ArticleId IdType="pmc">8423755</ArticleId>
            <ArticleId IdType="doi">10.1038/s41467-021-25684-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seba V, de Lima GG, Pereira BL, Silva G, Reinhardt LS, Arantes PR, et al. Development, Characterization and Cell Viability Inhibition of PVA Spheres Loaded with Doxorubicin and 4’-Amino-1-Naphthyl-Chalcone (D14) for Osteosarcoma. Polymers (Basel) 2021;13:2611.</Citation>
        </Reference>
        <Reference>
          <Citation>Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics 2012;16:284–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22455463</ArticleId>
            <ArticleId IdType="pmc">3339379</ArticleId>
            <ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
